Community Compounding Pharmacy entered the industry of in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 4461100, which describes it as a . For further clarification, the SIC classifies this business under the code 5912 and described it as a . The business provides service to the B2C market.
To acquire more information, please contact Jeff Sarace, Owner by calling (410) 749-1899 during business hours. You can also write to the business’ Single Location at 725 South Salisbury Boulevard, Salisbury, Maryland MD 21801. You can also visit the company’s website at communitypharmacymd.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Community Compounding Pharmacy |
Representative: | Jeff Sarace, Owner |
Place of Business: | 725 South Salisbury Boulevard, Salisbury, MD 21801 |
Contact Number: | (410) 749-1899 |
Website: | communitypharmacymd.com |
Type of Service: | |
SIC Number: | 5912 |
NAICS Number: | 4461100 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2007 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Community Compounding Pharmacy is a company operating from Wicomico, Maryland providing professional and relevant B2C variables. It was founded in 2007 and registered with the SIC code 5912 as , and with the NAICS code 4461100 as .
With a current employee count of 1 to 4, Community Compounding Pharmacy has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Jeff Sarace, Owner at (410) 749-1899 for related queries, or to locate its Single Location using the coordinates 38.35638,-75.60025.
The Single Location can also be found at the street address 725 South Salisbury Boulevard in Salisbury, Maryland 21801 and can be engaged online through the company website at communitypharmacymd.com, the company Twitter , and Facebook page .